Corline Biomedical AB (OSTO:CLBIO) Volatility: 63.97% (As of Jul. 02, 2026)


OSTO:CLBIO Corline Biomedical AB OSTO:CLBIO
43 GF Score
Price kr17.75
GF Value kr4.95
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Corline Biomedical AB Volatility?

Corline Biomedical AB OSTO:CLBIO -3.79% 43 Volatility is 63.97% as of Jul. 02, 2026. GuruFocus rates OSTO:CLBIO with a GF Score™ of 43/100 and a GF Value™ of kr4.95 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-07-02), Corline Biomedical AB's Volatility is 63.97%.


Corline Biomedical AB  (OSTO:CLBIO) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Corline Biomedical AB Volatility Related Terms


OSTO:CLBIO vs VRTX, REGN, ALNY: Volatility Comparison

For the Biotechnology subindustry, Corline Biomedical AB's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corline Biomedical AB Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Volatility distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Volatility falls into.


OSTO:CLBIO
43GF Score
Corline Biomedical AB OSTO:CLBIO
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corline Biomedical AB  (OSTO:CLBIO) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 63.97% mean?
Corline Biomedical AB (OSTO:CLBIO) has a Volatility of 63.97% as of Jul. 02, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Corline Biomedical AB and its competitors.
Is Corline Biomedical AB's Volatility too high?
Corline Biomedical AB's current Volatility is 63.97%. Overall, Corline Biomedical AB has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Corline Biomedical AB's Volatility compare to VRTX and REGN?
Corline Biomedical AB's Volatility of 63.97% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Corline Biomedical AB and its competitors. Corline Biomedical AB's current Volatility is 63.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corline Biomedical AB stock overvalued right now?
Based on GuruFocus' analysis, Corline Biomedical AB (OSTO:CLBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr4.95, compared to a current price of kr17.75 — trading 258.6% above its estimated fair value. The current Volatility is 63.97%. Corline Biomedical AB's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Corline Biomedical AB (OSTO:CLBIO), the current Volatility is 63.97% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Corline Biomedical AB (OSTO:CLBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Corline Biomedical AB stock appears to be overvalued. The current stock price of kr17.75 is trading 258.6% above its estimated GF Value™ of kr4.95. GuruFocus considers Corline Biomedical AB to be Significantly Overvalued.

Key valuation signals for OSTO:CLBIO:

  • Volatility: 63.97%
  • GF Value™: kr4.95 vs. price of kr17.75 (258.6% above fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the OSTO:CLBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Corline Biomedical AB Business Description

Address Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company offers a proprietary surface treatment technology, Corline Heparin Surface (CHS), which can be used in combination with all commonly used implant materials such as polymers (plastics) and various metals, but also for equipment where blood circulation occurs outside the body.
43GF Score

Get the complete analysis for OSTO:CLBIO

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.75
Price
kr4.95
GF Value